LRP5 and osteosclerosis: In contrast, other specific mutations in LRP5 affecting the binding of Dickkopf-1, an inhibitor of WNT signaling, result in gain-of-function of LRP5 and in osteosclerosis [79,80,81,82,83,84,85,86,87,88].